版本:
中国

BRIEF-Kuros FY revenue up at CHF 1.06 million

April 26 Kuros Biosciences AG:

* Merger successfully completed: Cytos Biotechnology and Kuros Biosurgery Holding combined their businesses to create Kuros Biosciences, a future leader in tissue repair and regeneration

* FY net loss of CHF 19.7 million ($19.86 million) versus loss CHF 5.8 million year ago

* Expects to receive CE mark certification for neuroseal in next months

* FY revenue of CHF 1.06 million versus CHF 144,000 year ago

Source text for Eikon: Further company coverage: ($1 = 0.9921 Swiss francs) (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐